Literature DB >> 11475330

Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid.

N Adam1, P Ghosh.   

Abstract

OBJECTIVE AND
DESIGN: Hyaluronan is the major non-proteinaceous component of joint synovial fluid and is responsible for the unique rheological and biological properties of this medium. In joint arthropathies the molecular weight and concentration of hyaluronan may change, thereby influencing joint physiology and function. Intra-articular administrated hyaluronan derived from a number of sources, has been used for the treatment of osteoarthritis, however, there is limited information on the molecular weight and polydispersity of these various commercial preparations. The objective of this study was to develop an accurate, convenient method by which the molecular weight and polydispersity of hyaluronan may be determined and then applied to characterise the hyaluronan in synovial fluid.
MATERIALS AND METHODS: Characterisation of the molecular parameters of hyaluronan of different origins and in ovine synovial fluid was accomplished using a multi-angle laser-light scattering (MALLS) detector coupled to a gel permeation chromatography (GPC) system, fitted with an automatic sample injector.
CONCLUSION: Seven commercially available hyaluronan preparations of reported molecular weight were analysed. The weight average molecular weight (Mw) and number average molecular weight (Mn) values obtained for 6 of the 7 preparations using the MALLS-GPC system were in good agreement with the reported values. The abnormally low values for the exception suggested that degradation of hyaluronan had occurred. The MALLS-GPC technique was then used to determine the molecular characteristics of the endogenous hyaluronan in normal ovine synovial fluids. While the Mws ranged from less than 1 x 10(6) Da to 7 x 10(6) Da the majority were between 1-3 x 10(6) Da. [mean Mw = 2.42 x 10(6), mean Mn = 2.21 x 10(6) Da]. The effects of freezing and thawing synovial fluid upon molecular weight of hyaluronan were also investigated and were found to diminish both Mz and Mw values.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475330     DOI: 10.1007/PL00000247

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  6 in total

1.  Rheologic behavior of osteoarthritic synovial fluid after addition of hyaluronic acid: a pilot study.

Authors:  Pierre Mathieu; Thierry Conrozier; Eric Vignon; Yves Rozand; Marguerite Rinaudo
Journal:  Clin Orthop Relat Res       Date:  2009-05-06       Impact factor: 4.176

2.  Hyaluronic acid production in Bacillus subtilis.

Authors:  Bill Widner; Régine Behr; Steve Von Dollen; Maria Tang; Tia Heu; Alan Sloma; Dave Sternberg; Paul L Deangelis; Paul H Weigel; Steve Brown
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Heterologous Production of Hyaluronic Acid in an ε-Poly-L-Lysine Producer, Streptomyces albulus.

Authors:  Tomohiro Yoshimura; Nobuyuki Shibata; Yoshimitsu Hamano; Kazuya Yamanaka
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

4.  Determination of hyaluronan molecular mass distribution in human breast milk.

Authors:  Han Yuan; Ripal Amin; Xin Ye; Carol A de la Motte; Mary K Cowman
Journal:  Anal Biochem       Date:  2015-01-09       Impact factor: 3.365

Review 5.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

6.  Physicochemical Properties of Hyaluronic Acid-Based Lubricant Eye Drops.

Authors:  Pasquale Aragona; Peter A Simmons; Hongpeng Wang; Tao Wang
Journal:  Transl Vis Sci Technol       Date:  2019-11-01       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.